GlaxoSmithKline
TOPIC
 / company

GlaxoSmithKline

GlaxoSmithKline
GlaxoSmithKline
The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.
Chairman / President
Jonathan Symonds
CEO / Managing Director
Dame Emma Natasha Walmsley
CFO / Finance Director
Julie Brown
Industry
Pharmaceutical
Website
gsk.com
Headquarters address
79 New Oxford Street, London, WC1A 1DG, United Kingdom
Stock Code
NYSE:GSK
LSE:GSK
Year founded
2000
Bill Gates speaks at a Save the Children event on vaccine equity in Germany last year. Photo: AP
Indonesia

Is Indonesia a ‘guinea pig’ in Bill Gates-backed TB vaccine trial?

The controversy began after President Prabowo Subianto said that Bill Gates was developing a tuberculosis vaccine to be tested in Indonesia.

8
United States

FDA approves GSK vaccine to combat meningococcal infections

Medicine

WHO recommends malaria vaccine for children, to be rolled out next year

videocam
Coronavirus pandemic

This man says he can beat Covid-19 with nasal sprays, not needles

Marty Moore, founder of Meissa Vaccines, says nasal sprays could be the future of the fight against Covid-19 and its variants by building better protection where the battle begins.

Marty Moore, the relentlessly upbeat founder of Meissa Vaccines Inc


CREDIT: Bloomberg Businessweek
Coronavirus pandemic

GlaxoSmithKline to manufacture Novavax Covid-19 vaccine in UK

The agreement has the potential to reduce the UK’s reliance on overseas vaccine supplies amid a spat with the EU over exports.

Health & Fitness

Chinese drugs firm aims to bring down cost of breast cancer treatment

Shanghai-based Genor Biopharma plans to seek regulatory approval for coprelotamab to be used in China on late-stage breast cancer patients.

videocam
Advertisement
Advertisement
Advertisement
Medicine

In pandemic lesson, drug maker Stada turns to China for supply security

Stada Arzneimittel, owned by private equity firms Bain Capital and Cinven, is turning to China to enhance its supply security and boost sales presence in Asia’s biggest pharmaceutical market.

videocam
An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa
Britain

UK watchdog investigates Chinese broadcaster for airing ‘forced confession’

Briton Peter Humphrey and his wife, Yu Yingzeng, were sentenced in China in 2014 for illegally obtaining and selling private records of Chinese citizens.

Disease

Malawi becomes world’s first country to roll out malaria vaccine

After more than three decades in development and almost US$1 billion in investment, the new vaccine began to be distributed in Lilongwe, the nation’s capital.

Corruption in China

China, US and hard cash are emboldening corporate whistle-blowers

videocam
China offers many opportunities for corporate whistle-blowers who want to obtain a reward for reporting violations of America’s Foreign Corrupt Practices Act to the US Securities and Exchange Commission. Photo: Bloomberg
Medicine

U.S. FDA approves GSK next-generation HIV drug dolutegravir

Scanning electromicrograph of an HIV-infected T cell. Photo: NIAID
Wellness

Alibaba partners with GSK for online HPV vaccine service

Corruption in China

US judge dismisses lawsuit against GSK over China whistle-blower

Corruption in China

How Western firms in China can avoid the corruption dragnet

Shelves of milk powder at a supermarket in Beijing in July 2013, amid an investigation into alleged price-fixing by foreign firms in the infant formula sector. Photo: AFP
Business Insider

New joint venture to study electronic implants for conditions like diabetes and asthma

Layers of nerve cells in the retina. Photo: Flickr/NIH Image Gallery

Nowhere to hide from bribery laws

At a closed-door trial held last month in Hunan province, one-time high-flying business executive Mark Reilly was handed a three-year suspended prison sentence for his role in the largest corporate bribery scandal involving a foreign firm in China.

Hong Kong hot spot for lawyers

When Cathy Palmer first came to Hong Kong as a US prosecutor more than 20 years ago, she was chasing heroin-smuggling triads who later sent a booby-trapped package to her Brooklyn office.

Advertisement
Advertisement
Advertisement

Multinationals in China on alert in wake of GSK case

In the wake of the Chinese government's punishment of GSK and some of its former senior executives for corruption, multinationals are changing their behaviour and strategies in China, said industry observers.

The central government's corruption probe into GSK prompted other multinationals to increase their attention on compliance. Photo: AP
Alibaba

Mr. Shangkong | The tale of Alibaba and GSK a sign of China's rise on world stage

Alibaba celebrated its landmark US$21.8 billion listing in New York on Friday - the largest IPO in American history - on the same day that GlaxoSmithKline was hit by a record fine of US$500 million imposed by the central government.

GlaxoSmithKline hit with record 3b yuan fine for bribing Chinese doctors

China has imposed a record fine of three billion yuan (HK$3.78 billion) on British pharmaceuticals giant GlaxoSmithKline (GSK) for bribing doctors to use its drugs.

GlaxoSmithKline China health care unit 'part of US probe'

A US anti-bribery probe into GSK touched on the firm's Chinese consumer health care business in 2012, internal documents show, suggesting the drugmaker's compliance problems in China could go wider than previously revealed.

GSK confirms it has conducted an investigation into procurement practices in consumer health care in China, but says it does not find any 'unethical conduct'. Photo: Reuters

British investigator Peter Humphrey jailed for 2.5 years for buying private data

A year after his detention sent shockwaves through China's booming due-diligence industry, British corporate investigator Peter Humphrey admitted in a Shanghai court yesterday that he paid contractors for private information on Chinese citizens for almost a decade.

A television screen shows British investigator Peter Humphrey (centre) at his trial on charges he breached China's privacy laws. Photo: AFP

Live | LIVE: Chinese court jails GSK investigator Peter Humphrey for 2½ years on privacy charges

The British corporate investigator Peter Humphrey and his Chinese-American wife Yu Yingzeng were handed fines and jail sentences of two years in Shanghai on Friday after being convicted on charges of "illegally obtaining private information".

videocam

GSK sleuth Peter Humphrey caught by increasing Chinese restrictions on obtaining information

Briton Peter Humphrey and his American wife, Yu Yingzeng, face trial on Friday for illegally obtaining personal information of Chinese citizens.

Son visits investigator Peter Humphrey and his wife in detention

The only child of corporate investigators Peter Humphrey and Yu Yingzeng has been allowed to visit his parents in their detention centre in Pudong, Shanghai.

Shanghai police arrested Peter Humphrey (right) and Yu Yingzeng for illegally obtaining information that infringed upon the privacy of Chinese citizens. Photo: CCTV

'I was only trying to help': Peter Humphrey's letter to son insists China detective work was for public good

Corporate sleuth Peter Humphrey believes he worked for the public good by helping victims of crime, according to a letter seen by the Post that he wrote to his son Harvey from prison.

Peter Humphrey believes he worked for the public good by helping victims of crime. Photo: SCMP Pictures

Update | ‘We deeply regret breaking the law’: GSK-linked Peter Humphrey and wife formally charged in China

Prosecutors have filed charges against British investigator Peter Humphrey and his American wife, after the couple were detained last year following work they did for GlaxoSmithKline.

US expresses concern over secret trial of GSK investigators in China

The United States has expressed concern after its officials were barred from the Chinese trial of two investigators for British drugmaker GlaxoSmithKline who are accused of illegally buying and selling private information.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement